Huimin Wang Biography and Net Worth

Huimin Wang, M.D., is the vice president for Japan, Asia and Pacific at Edwards Lifesciences, a role he has held since 2010.

Edwards is a medical technology company specializing in artificial heart valves and hemodynamic monitoring.

Before taking over for Japan, Asia and Pacific, Dr. Wang oversaw Edwards’ Japan and intercontinental divisions. He joined the company (formerly known as Baxter International) in 1993, and he has held numerous roles during his tenure, such as senior manager of strategy development and president of medical systems and devices.

Before his time at Edwards, Dr. Wang worked as a senior associate with Booz, Allen & Hamilton, an IT consulting firm in Chicago, as co-founder and VP for Integrated Strategies, a consulting and venture management firm, and as an associate at management consulting firm, McKinsey & Company.

He previously served as an anesthesiology resident and staff physician at Tokyo’s Keio University Hospital.

Dr. Wang has also served on the board of The Ascend Foundation, a nonprofit organization with a mission to advocate for and assist Pan-Asians in North America to become leaders, innovators and models for change.

He earned his M.D. at Japan’s Kagoshima University and his M.B.A. at the University of Chicago.

What is Huimin Wang's net worth?: The estimated net worth of Huimin Wang is at least $7.40 million as of July 8th, 2021. Dr. Wang owns 104,377 shares of Edwards Lifesciences stock worth more than $7,399,912 as of March 31st. This net worth evaluation does not reflect any other assets that Dr. Wang may own. Learn More about Huimin Wang's net worth.
How do I contact Huimin Wang?: The corporate mailing address for Dr. Wang and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at investor_relations@edwards.com. Learn More on Huimin Wang's contact information.
Has Huimin Wang been buying or selling shares of Edwards Lifesciences?: Huimin Wang has not been actively trading shares of Edwards Lifesciences in the last ninety days. Most recently, Huimin Wang sold 3,675 shares of the business's stock in a transaction on Tuesday, March 8th. The shares were sold at an average price of $107.60, for a transaction totalling $395,430.00. Learn More on Huimin Wang's trading history.
Who are Edwards Lifesciences' active insiders?: Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.
Are insiders buying or selling shares of Edwards Lifesciences?: In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 28 times. They sold a total of 243,407 shares worth more than $19,507,015.48. The most recent insider tranaction occured on March, 26th when CFO Scott B Ullem sold 11,250 shares worth more than $797,287.50. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.
Information on this page was last updated on 3/26/2025.

Huimin Wang Insider Trading History at Edwards Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/8/2022	Sell	3,675	$107.60	$395,430.00
1/7/2022	Sell	6,350	$122.16	$775,716.00
11/8/2021	Sell	6,350	$119.40	$758,190.00
9/8/2021	Sell	6,350	$121.25	$769,937.50
8/9/2021	Sell	6,350	$115.54	$733,679.00
7/8/2021	Sell	6,350	$106.72	$677,672.00	104,377
4/8/2021	Sell	6,350	$84.88	$538,988.00	61,922
3/8/2021	Sell	6,350	$81.37	$516,699.50	99,563
2/11/2021	Sell	11,745	$86.81	$1,019,583.45	104,958
1/15/2021	Sell	11,730	$87.27	$1,023,677.10	105,027
12/14/2020	Sell	11,733	$84.53	$991,790.49	105,111
10/9/2020	Sell	11,733	$82.60	$969,145.80	105,276
8/11/2020	Sell	11,733	$76.04	$892,177.32	105,441
7/6/2020	Sell	591	$70.00	$41,370.00	93,792
5/18/2020	Sell	1,717	$216.68	$372,039.56	31,435
5/11/2020	Sell	3,883	$219.03	$850,493.49	36,094
4/13/2020	Sell	3,911	$212.99	$833,003.89	35,147
3/30/2020	Sell	4,948	$198.10	$980,198.80	36,131
1/6/2020	Sell	4,650	$230.95	$1,073,917.50	36,898
12/9/2019	Sell	4,650	$238.56	$1,109,304.00	36,898
11/5/2019	Sell	4,650	$234.83	$1,091,959.50	36,898
10/4/2019	Sell	4,650	$223.18	$1,037,787.00	36,898
9/5/2019	Sell	4,650	$222.06	$1,032,579.00	36,898
8/5/2019	Sell	4,650	$211.54	$983,661.00	36,898
7/5/2019	Sell	4,650	$186.17	$865,690.50	36,898
6/5/2019	Sell	4,650	$175.50	$816,075.00	36,823
4/5/2019	Sell	4,650	$189.31	$880,291.50	35,971
3/25/2019	Sell	4,650	$188.60	$876,990.00	35,874
1/4/2019	Sell	4,000	$145.33	$581,320.00	35,224
12/6/2018	Sell	3,800	$155.87	$592,306.00	35,024
11/6/2018	Sell	33,800	$150.43	$5,084,534.00	81,665
10/5/2018	Sell	3,800	$152.79	$580,602.00	81,665
9/5/2018	Sell	3,800	$141.73	$538,574.00	77,865
8/6/2018	Sell	3,800	$144.99	$550,962.00	88,483
7/5/2018	Sell	3,800	$146.60	$557,080.00
6/5/2018	Sell	3,800	$142.84	$542,792.00	88,388
5/4/2018	Sell	3,800	$131.93	$501,334.00	85,016
3/19/2018	Sell	3,800	$141.84	$538,992.00
12/5/2016	Sell	13,650	$83.53	$1,140,184.50
11/7/2016	Sell	13,650	$91.29	$1,246,108.50
10/5/2016	Sell	13,650	$120.04	$1,638,546.00
9/6/2016	Sell	13,650	$115.72	$1,579,578.00
8/5/2016	Sell	13,650	$113.03	$1,542,859.50
7/5/2016	Sell	13,650	$98.44	$1,343,706.00
6/6/2016	Sell	13,650	$101.34	$1,383,291.00	89,272
5/5/2016	Sell	13,650	$103.36	$1,410,864.00	81,480
4/5/2016	Sell	13,650	$103.97	$1,419,190.50	81,480
3/7/2016	Sell	13,650	$87.17	$1,189,870.50	81,299
2/5/2016	Sell	13,650	$83.46	$1,139,229.00
1/5/2016	Sell	13,650	$78.50	$1,071,525.00	67,649
12/4/2015	Sell	6,880	$157.96	$1,086,764.80	33,824
11/5/2015	Sell	6,920	$156.01	$1,079,589.20	34,174
10/5/2015	Sell	6,920	$154.30	$1,067,756.00	34,174
9/4/2015	Sell	6,920	$135.19	$935,514.80	34,174
7/6/2015	Sell	6,920	$143.95	$996,134.00
6/5/2015	Sell	6,920	$131.39	$909,218.80
4/6/2015	Sell	6,920	$140.24	$970,460.80
2/6/2015	Sell	6,920	$134.79	$932,746.80
1/5/2015	Sell	6,920	$126.60	$876,072.00
11/5/2014	Sell	5,600	$120.26	$673,456.00
10/6/2014	Sell	5,600	$107.00	$599,200.00
9/5/2014	Sell	5,600	$98.29	$550,424.00
7/7/2014	Sell	5,600	$87.79	$491,624.00
6/5/2014	Sell	5,600	$80.73	$452,088.00
4/7/2014	Sell	5,600	$74.03	$414,568.00	31,549
1/6/2014	Sell	5,600	$67.14	$375,984.00	31,337
12/5/2013	Sell	4,650	$64.65	$300,622.50	31,337
10/4/2013	Sell	4,850	$72.19	$350,121.50	31,337
9/5/2013	Sell	4,850	$71.24	$345,514.00	31,337
8/5/2013	Sell	4,850	$72.30	$350,655.00	31,337
7/5/2013	Sell	4,850	$65.69	$318,596.50
6/5/2013	Sell	4,850	$65.11	$315,783.50
10/5/2012	Sell	6,250	$109.88	$686,750.00

See Full Table

Huimin Wang Buying and Selling Activity at Edwards Lifesciences

Edwards Lifesciences Company Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Today's Range

Now: $70.90

$70.63

$71.66

50 Day Range

MA: $71.49

$67.92

$76.23

2 Week Range

Now: $70.90

$58.93

$95.73

Volume

4,513,774 shs

Average Volume

4,789,501 shs

Market Capitalization

$41.68 billion

P/E Ratio

10.17

Dividend Yield

N/A

Beta

1.12